Product
Rabbit ATG
Aliases
rabbit ATG
6 clinical trials
20 indications
Indication
Aplastic AnemiaIndication
Fanconi AnemiaIndication
Severe Marrow FailureIndication
Myelodysplastic SyndromeIndication
acute myelogenous leukemiaIndication
Kidney Transplant RejectionIndication
Pediatric Kidney DiseaseIndication
LeukemiaIndication
LymphoidIndication
myeloidIndication
Myelodysplastic SyndromesIndication
MyelofibrosisIndication
lymphomaIndication
malignantIndication
Multiple MyelomaIndication
Waldenstrom MacroglobulinemiaIndication
Acquired Pure Red Cell AplasiaIndication
Paroxysmal Nocturnal HemoglobinuriaIndication
Stem Cell TransplantationClinical trial
A Study of T-Cell Replete, HLA-Mismatched Haploidentical Bone Marrow Transplantation With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Lacking HLA-Matched Related DonorStatus: Recruiting, Estimated PCD: 2025-08-31
Clinical trial
A Phase II Trial of HSCT for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and FludarabineStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Induction Therapy of Thymoglobulin Versus Basiliximab in the Prevention of Acute Rejection After Pediatric Kidney TransplantationStatus: Completed, Estimated PCD: 2022-07-27
Clinical trial
A Pilot Trial Examining Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic Stem Cell Transplant Recipients Using Myeloablative Busulfan and FludarabineStatus: Completed, Estimated PCD: 2019-06-07
Clinical trial
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.Status: Recruiting, Estimated PCD: 2035-05-01
Clinical trial
Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersStatus: Withdrawn, Estimated PCD: 2023-09-18